The National Institutes of Health (NIH) is issuing a Notice of Funding Opportunity (NOFO) for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting investigator-initiated, high-risk multi-center clinical trials that propose innovative approaches to address diabetes, digestive diseases, and kidney and urologic diseases. Applicants are required to develop a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity and consideration of health disparities, which will be assessed as part of the review process. The funding mechanisms include a two-part process: the U34 Planning Cooperative Agreement for planning activities and the U01 Cooperative Agreement for executing the clinical trials. Applications must comply with stringent guidelines, including detailed study designs, ethical considerations, and human subjects protection plans. The program underscores the importance of substantial engagement with affected communities and diverse populations throughout the research process. Key deadlines for application submissions are set to start in early 2024, and the maximum project period is five years with funding contingent on NIH appropriations. The NOFO highlights the NIH's commitment to improving public health through research while addressing significant disparities faced by underrepresented communities.